Related Experiment Video
Updated: Apr 17, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
Sweet syndrome as terminal event in ruxolitinib-treated myelofibrosis
Basabi Chatterjee1, Usama Rqieh, Paul Greaves
1Department of Haematology, Barking, Havering and Redbridge University Hospitals NHS Trust, London, UK. basabi.chatterjee2@bartshealth.nhs.uk.
No abstract available in PubMed .
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Nephrotic Syndrome I : Introduction
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists